Business context and reporting period
Filing identity: The supplied 10-Q is for General Enterprise Ventures, Inc. (GEVI), not an issuer named Citrotech Inc. GEVI reports through its subsidiary Mighty Fire Breaker LLC (MFB), which sells EPA-approved CitroTech fire-prevention products and related technology. The unaudited quarter ended March 31, 2024; comparisons are with the quarter ended March 31, 2023.
Financial results and liquidity
| Metric | Q1 2024 | Q1 2023 / prior date |
|---|---|---|
| Revenue | $433,018 | $55,595 |
| Gross profit / gross margin | $343,146 / 79.2% | $41,741 / 75.1% |
| Operating expenses | $2,979,692 | $395,177 |
| Operating loss | $(2,636,546) | $(353,436) |
| Net loss | $(3,519,710) | $(353,611) |
| Cash used in operations | $(343,660) | $(176,905) |
| Cash / current assets | $371,095 / $1,252,314 | $549,755 / $1,218,056 at Dec. 31, 2023 |
| Current liabilities | $1,461,385 | $1,617,785 at Dec. 31, 2023 |
| Total liabilities | $1,490,215 | $1,667,832 at Dec. 31, 2023 |
Revenue increased about 679% year over year, but the larger operating loss reflects increased expenses, including $2.398 million of stock-based compensation, and an $882,279 loss on debt settlement. No income-tax provision was recorded. Cash fell by $178,660 during the quarter; $165,000 of financing cash came from Series C preferred-stock issuance, and there were no investing cash flows. The balance sheet shows a $209,071 working-capital deficit. The company had a $73.0 million accumulated deficit and disclosed substantial doubt about its ability to continue as a going concern.
Material changes and unusual items
- Q1 revenue rose from $55,595 to $433,018, while net loss widened from $353,611 to $3,519,710. Marketing expense increased to approximately $110,206 from approximately $11,592.
- Professional fees were $2,672,129 in the income statement. Management attributes much of the operating-expense increase to stock compensation: $1.702 million in common stock and $696,000 in Series C preferred stock were issued for services. The filing’s MD&A separately presents stock-based expense categories totaling $2.398 million.
- The company settled a $120,000 promissory note and a $54,000 convertible note, plus accrued interest, through common-stock issuances. The reported combined settlement loss was $882,279. These notes were no longer outstanding at March 31.
- Common shares outstanding declined from 97,545,388 to 36,302,150, reflecting cancellation of 65 million shares and new issuances. Series C preferred shares are convertible at 20 common shares per preferred share; 2,471,832 were outstanding at quarter-end. Series A preferred shares carry 1,000 votes each and were amended in March 2024 to remove their conversion feature.
- Amounts due to related parties remained $1,309,077, consisting of unsecured, non-interest-bearing demand loans. MFB’s acquisition terms also provide the vendor a 10% royalty on gross sales of products in the MFB product family.
Outlook, risks, and contingencies
Management plans to raise additional funds and/or refinance indebtedness to support operations in 2024 and beyond, but provides no assurance it can do so. The company expects significant operating expenditures and says future viability depends on raising capital and generating revenue and profits. No quantified revenue or earnings guidance is provided.
Customer concentration is substantial: three customers represented 90.21% of Q1 revenue, and four customers together represented 91.15% of quarter-end accounts receivable. All reported Q1 purchases were concentrated among a small group of suppliers. Management says it monitors customer credit risk; no allowance for doubtful accounts was recorded. About $112,000 of cash exceeded FDIC insurance limits at quarter-end.
Management concluded disclosure controls were ineffective as of March 31, citing no functioning audit committee, insufficient independent directors, inadequate segregation of duties, and management dominance by one individual. The filing warns that weaknesses could lead to financial-statement errors or restatement. GEVI reported no material legal proceedings and no material off-balance-sheet arrangements.
Investor facts to verify
- Confirm the issuer and security being analyzed: this filing is for General Enterprise Ventures, Inc.; CitroTech is a product/brand referenced in its business description.
- Reconcile the filing’s liquidity disclosures: MD&A reports a $209,071 working-capital deficit, while the going-concern note refers to negative working capital of $3.8 million.
- Review the detail and valuation of stock-based compensation and debt-settlement losses, which substantially increased reported expenses and loss.
- Assess near-term funding needs, the $1.309 million related-party demand balance, customer/supplier concentration, and potential dilution from convertible Series C preferred stock.
- Check the share count, voting rights, and conversion terms following the 65 million-share cancellation and March 2024 Series A amendment.